FORMULATION AND OPTIMIZATION OF RAFT FORMING CHEWABLE TABLET CONTAINING LAFUTIDINE

Abstract

Lafutidine is a new histamine H2- receptor antagonist having biological half-life of 1.92 h. Due to its selective absorption from upper part of gastrointestinal tract the gastroretentive drug delivery is desired in order to enhance its bioavailability. The aim of research was to formulate chewable tablets of lafutidine along with raft forming agent, antacid and gas generating agent. Tablets were prepared by wet granulation method and evaluated for raft strength, acid neutralization capacity, weight variation, % drug content, and in vitro drug release. Various raft-forming agents were used in preliminary screening. A 32 full factorial design was used for optimization in present study. Amount of calcium carbonate and ratio of sodium alginate to pectin were used as independent variables while raft strength and acid neutralizations capacity were used as dependent variables. Batch F8 was selected as optimized formulation based on maximum raft strength and good acid neutralization capacity. Drug-excipients compatibility study showed no interaction between drug and excipients. Stability study of the optimized formulation showed that the tablets were stable at accelerated environmental conditions for 1 month. It was concluded that raft forming chewable tablets prepared using an optimum amount of sodium alginate, pectin and calcium carbonate could be an efficient dosage form in the treatment of gastro oesophageal reflux disease.

Authors and Affiliations

Dasharath M. Patel, Dimpal G. Patel, Chhagan N. Patel

Keywords

Related Articles

FORMULATION AND EVALUATION OF NATEGLINIDE SUSTAINED RELEASE TABLETS

The objective of the present investigation was to design suitable sustained release tablet formulation of Nateglinide by using different polymers such as hydroxy propyl methyl cellulose K15M, xanthan gum, guar gum as rel...

FORMULATION AND DEVELOPMENT OF STABLE METAXALONE NANOSUSPENSION USING 32 FACTORIAL DESIGN

Nanosuspensions are the dispersions of nanosized particles in a suitable vehicle prepared using surfactants or solubilizers to aid in nanosize distribution. Nanosuspension is best suited for dosage form development of po...

FORMULATION, OPTIMIZATION AND IN VITRO CHARACTERIZATION OF LETROZOLE LOADED SOLID LIPID NANOPARTICLES

Letrozole (LTZ) is an oral non-steroidal aromatase inhibitor for the treatment of hormonally responsive breast cancer after surgery. The objective of the current study is to prepare and evaluate Solid lipid nanoparticles...

ISOLATION AND IDENTIFICATION OF STEROID AND FLAVONOID GLYCOSIDES FROM THE FLOWERS OF ALLIUM GRAMINEUM

The isolation and identification of β-sitosterol 3-O-β-glucopyranoside, quercetin 3-O-β-glucopyranoside, isorhamnetin 3,4'-di-O-β-glucopyranoside and isorhamnetin 3,7-di-O-β-glucopyranoside from the flowers of Allium gra...

EFFECT OF PHOSPHATASES ACTIVITY IN THE HEPATOPANCREAS AND MUSCLE OF THE FRESH WATER FEMALE FIELD CRAB, SPIRALOTHELPHUSA HYDRODROMA (HERBST) TREATED WITH CYPERMETHRIN

The fresh water field crab, Spiralothelphusa hydrodroma is an important human food source in parts of South India and the crab is constantly exposed to pesticides, which are used extensively to control agricultural pests...

Download PDF file
  • EP ID EP625123
  • DOI -
  • Views 71
  • Downloads 0

How To Cite

Dasharath M. Patel, Dimpal G. Patel, Chhagan N. Patel (2015). FORMULATION AND OPTIMIZATION OF RAFT FORMING CHEWABLE TABLET CONTAINING LAFUTIDINE. International Journal of Pharmaceutical Sciences and Drug Research, 7(3), 229-234. https://europub.co.uk./articles/-A-625123